Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and DesignTohru Minamino, Shinya Fujiki, Kenichi Iijima et al.|Diabetes Therapy|2020Cited by 21
A mathematical model to predict protein wash out kinetics during whole-lung lavage in autoimmune pulmonary alveolar proteinosisKeiichi Akasaka, Koh Nakata, Nobutaka Kitamura et al.|American Journal of Physiology-Lung Cellular and Molecular Physiology|2014Cited by 6